W: (609) 924-7207
M: (732) 766-3563
June 15, 2015
Mr. Taylor to Seek Development Opportunities and Establish Relationships With Corporate and Organizational Partners
Washington, DC (May 5, 2015) – The Global Liver Institute (GLI) is pleased to announce the appointment of Rolf Taylor to the position of Executive Vice President.
Mr. Taylor will support and guide GLI in its quest to identify partners for collaboration, support and sponsorship to achieve its mission to improve awareness of liver disease, increase access to treatments, and to develop comprehensive healthcare to improve outcomes.
“We’re delighted to have Rolf join us on the GLI team,” said Donna Cryer, Founder and President of GLI. “With more than 25-years of experience in the healthcare industry, and an extensive knowledge of the advocacy universe, Rolf has the vision, knowledge and know-how to help make GLI a success.”
Mr. Taylor’s career spans work at both healthcare manufacturers as well as at non-profit advocacy organizations, most recently at the COPD Foundation, where he served as Senior Director. Mr. Taylor is well-known within the liver advocacy committee, having served as the National Director of Corporate Relations at the American Liver Foundation. Over the course of his career, Mr. Taylor has also worked at the Focused Ultrasound Foundation, public relations firm Fleishman-Hillard, Quintiles, Roche Pharmaceuticals and GlaxoSmithKline.
“I’m thrilled to join Donna and her team – and to return again to working within the liver disease community,” said Mr. Taylor. “Liver disease represents a significant global health issue, and through its work, GLI has a tremendous opportunity to improve liver health and well-being by bringing diverse stakeholders together to serve a common cause. I look forward to working with GLI as we identify new partners, new collaborative opportunities and new thought leaders who together can help change the face of liver disease. “
The Global Liver Institute (GLI) was founded by Mrs. Cryer in 2014 to facilitate collaboration among patient advocates, policymakers, regulators, health systems and payers to help co-design and accelerate the adoption of solutions that can improve liver health and lead to the better treatment of liver diseases.
Founded in 2014, The Global Liver Institute is redefining traditional advocacy to defeat liver disease. Through the creation of high-level, collaborative partnerships with public, private and academic institutions, GLI drives the development of innovative solutions to complex problems that can then be scaled to impact patients, clinicians or other stakeholder groups. To address the low level of awareness and stigma associated with liver disease, GLI recruits high-profile celebrities and media organizations to spread knowledge and understanding. By bringing together diverse stakeholders, promoting collaboration and scaling novel approaches, GLI hopes to improve the effectiveness of the liver community – and one day eradicate liver disease.